Access cutting-edge opioid use disorder treatment through this clinical trial at a research site in Bel Air. Study-provided care at no cost to qualified participants.
Access opioid use disorder specialists in Bel Air at no cost
This study follows strict safety protocols and ethical guidelines
All study-related opioid use disorder treatment provided free
This study is designed to elucidate the role of the orexin neurotransmitter system in sleep disturbance and circadian rhythms of stress that might in turn influence relapse behaviors in persons on medication-assisted treatments (MAT) who are in early recovery from opioid use disorder (OUD). Briefly, the study will enroll recently abstinent OUD patients (N=200) maintained on either extended-release naltrexone (XR-NTX), buprenorphine, or methadone. Within each MAT group, participants will be rando
Sponsor: Johns Hopkins University
Check if you qualify for this opioid use disorder clinical trial in Bel Air, MD
If you're searching for opioid use disorder treatment options in Bel Air, MD, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Bel Air research site is actively enrolling participants for this clinical trial. You'll receive care from experienced opioid use disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.